Streetbeat News

Products Services

CERO

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) will present data on its lead compound CER-1236 at the Global Cell & Gene Therapy Summit 2024. The data supports the use of CER-1236 in treating acute myeloid leukemia (AML) and shows no adverse toxicities in healthy tissue. Initial human trials are anticipated upon IND clearance.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 12:13 pm

CRL

Charles River Laboratories International, Inc. (NYSE:CRL) and AAVantgarde have signed a CDMO agreement to produce GMP plasmid DNA for AAVantgarde's Stargardt's disease program. This collaboration leverages Charles River's expertise in manufacturing and AAVantgarde's proprietary AAV vector platforms.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 12:12 pm

ACN

Accenture has acquired Excelmax Technologies, though the terms of the deal were not disclosed. This acquisition is expected to enhance Accenture's technological capabilities.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 12:12 pm

TNXP

Tonix Pharmaceuticals has reported its final pre-NDA meeting with the FDA for Tonmya, a potential new non-opioid analgesic for fibromyalgia. The NDA submission is targeted for the second half of 2024, with potential FDA approval in the second half of 2025.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 12:08 pm

BBY

NIU

Niu Technologies (NASDAQ:NIU) has announced a large-scale retail expansion to over 800 Best Buy stores across the U.S. This move aims to accelerate the adoption of NIU's electric kick-scooters and e-bikes. Consumers can now purchase these products in-store, online, and via the Best Buy Mobile App.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 12:07 pm

AVTE

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) announced it will explore strategic alternatives, including potential acquisitions, mergers, or other transactions, following the halt of its Phase 3 clinical trial for Inhaled iMatinib Pulmonary Arterial Hypertension.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 12:06 pm

KULR

KULR Technology Group, Inc. (NYSE:KULR) has secured a $400,000 contract from NASA for automated battery cell testing, with total orders expected to reach $2 million over several quarters. The contract is part of NASA's Artemis Program, which requires stringent certification for lithium-ion cells used in manned space missions.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 12:06 pm

CRBG

Corebridge Financial, Inc. (NYSE:CRBG) has renamed its direct-to-consumer life insurance business from AIG Direct to Corebridge Direct. Customers can now visit corebridgedirect.com or call 800-294-4544 for quotes and coverage evaluations.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 12:05 pm

PLSE

Pulse Biosciences has received FDA Breakthrough Device Designation for its cardiac surgery system that uses nanosecond pulsed field ablation technology to treat atrial fibrillation.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 12:02 pm

ENPH

Enphase Energy has started U.S. shipments of its IQ8 commercial microinverters, supported by the Inflation Reduction Act, which aims to advance renewable energy and job creation.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 12:02 pm